This model identifiedtwo inhibitors, among which 8012-3246 demonstrated potent PLK2 inhibition,marked cytotoxicity, and strong antiproliferative effects in CRC cells.In addition, the compound exhibited high selectivity. This evidence concerns the gene PLK2 and colorectal carcinoma.